tiprankstipranks
Trending News
More News >
Kangji Medical Holdings Limited (HK:9997)
:9997
Hong Kong Market
Advertisement

Kangji Medical Holdings Limited (9997) Ratios

Compare
3 Followers

Kangji Medical Holdings Limited Ratios

HK:9997's free cash flow for Q2 2025 was ¥0.79. For the 2025 fiscal year, HK:9997's free cash flow was decreased by ¥ and operating cash flow was ¥0.57. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.14 17.72 20.33 27.18 38.84
Quick Ratio
4.85 17.16 19.64 26.59 38.15
Cash Ratio
3.85 14.03 18.34 25.34 29.58
Solvency Ratio
1.27 1.64 1.88 3.61 3.09
Operating Cash Flow Ratio
1.21 2.20 2.08 3.74 2.93
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
¥ 1.82B¥ 3.06B¥ 2.86B¥ 3.04B¥ 2.85B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.01 0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 0.01 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.18 1.17 1.18 1.04 1.03
Debt Service Coverage Ratio
0.00 145.37 258.50 1.78K 6.39K
Interest Coverage Ratio
0.00 196.04 237.88 2.13K 7.42K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
<0.01 0.04 0.04 <0.01 <0.01
Net Debt to EBITDA
-2.76 -5.67 -4.72 -6.90 -6.98
Profitability Margins
Gross Profit Margin
79.00%80.04%80.78%81.55%84.36%
EBIT Margin
56.48%47.78%71.85%60.52%60.93%
EBITDA Margin
59.02%50.17%74.60%61.90%62.39%
Operating Profit Margin
56.48%47.78%56.72%60.52%60.93%
Pretax Profit Margin
65.15%63.58%71.61%77.43%60.62%
Net Profit Margin
53.63%54.43%60.88%66.18%48.93%
Continuous Operations Profit Margin
53.63%48.84%58.65%66.18%50.67%
Net Income Per EBT
82.31%85.61%85.01%85.46%80.72%
EBT Per EBIT
115.35%133.06%126.26%127.95%99.49%
Return on Assets (ROA)
18.37%11.82%12.01%13.47%8.29%
Return on Equity (ROE)
21.49%13.81%14.19%14.01%8.52%
Return on Capital Employed (ROCE)
22.63%10.86%11.64%12.76%10.58%
Return on Invested Capital (ROIC)
18.62%8.33%9.53%10.91%8.86%
Return on Tangible Assets
18.38%13.22%13.55%13.47%8.29%
Earnings Yield
5.84%6.86%5.54%5.77%2.08%
Efficiency Ratios
Receivables Turnover
3.76 4.11 4.82 8.51 5.85
Payables Turnover
5.53 5.41 7.28 6.97 7.01
Inventory Turnover
1.71 1.76 1.43 1.86 1.56
Fixed Asset Turnover
3.81 3.24 2.93 6.43 6.03
Asset Turnover
0.34 0.22 0.20 0.20 0.17
Working Capital Turnover Ratio
0.58 0.30 0.26 0.23 0.31
Cash Conversion Cycle
244.77 229.23 280.17 186.54 244.99
Days of Sales Outstanding
97.10 88.90 75.73 42.89 62.37
Days of Inventory Outstanding
213.65 207.76 254.57 195.99 234.65
Days of Payables Outstanding
65.99 67.43 50.12 52.34 52.03
Operating Cycle
310.76 296.66 330.30 238.89 297.02
Cash Flow Ratios
Operating Cash Flow Per Share
0.46 0.36 0.26 0.36 0.23
Free Cash Flow Per Share
0.41 0.28 0.20 0.33 0.21
CapEx Per Share
0.04 0.07 0.06 0.03 0.02
Free Cash Flow to Operating Cash Flow
0.90 0.79 0.76 0.93 0.92
Dividend Paid and CapEx Coverage Ratio
0.32 1.38 1.25 5.76 0.96
Capital Expenditure Coverage Ratio
10.30 4.77 4.22 14.12 12.40
Operating Cash Flow Coverage Ratio
583.72 9.54 6.51 107.70 43.77
Operating Cash Flow to Sales Ratio
0.51 0.45 0.41 0.63 0.43
Free Cash Flow Yield
5.04%4.51%2.82%5.11%1.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.14 14.59 18.05 17.33 48.10
Price-to-Sales (P/S) Ratio
9.20 7.94 10.99 11.47 23.54
Price-to-Book (P/B) Ratio
3.71 2.01 2.56 2.43 4.10
Price-to-Free Cash Flow (P/FCF) Ratio
19.83 22.16 35.47 19.55 59.25
Price-to-Operating Cash Flow Ratio
17.89 17.52 27.06 18.17 54.47
Price-to-Earnings Growth (PEG) Ratio
-8.40 1.94 2.23 0.41 1.60
Price-to-Fair Value
3.71 2.01 2.56 2.43 4.10
Enterprise Value Multiple
12.82 10.16 10.01 11.63 30.75
Enterprise Value
7.92B 4.72B 5.87B 4.97B 9.81B
EV to EBITDA
12.82 10.16 10.01 11.63 30.75
EV to Sales
7.57 5.10 7.47 7.20 19.18
EV to Free Cash Flow
16.31 14.23 24.10 12.27 48.29
EV to Operating Cash Flow
14.73 11.25 18.39 11.40 44.39
Tangible Book Value Per Share
2.20 2.98 2.70 2.66 3.08
Shareholders’ Equity Per Share
2.20 3.11 2.79 2.66 3.08
Tax and Other Ratios
Effective Tax Rate
0.18 0.23 0.18 0.15 0.16
Revenue Per Share
0.89 0.79 0.65 0.56 0.54
Net Income Per Share
0.48 0.43 0.40 0.37 0.26
Tax Burden
0.82 0.86 0.85 0.85 0.81
Interest Burden
1.15 1.33 1.00 1.28 0.99
Research & Development to Revenue
0.07 0.14 0.08 0.05 0.05
SG&A to Revenue
0.08 0.11 0.09 0.09 0.09
Stock-Based Compensation to Revenue
<0.01 <0.01 0.01 0.01 0.04
Income Quality
0.96 0.71 0.67 0.95 0.88
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis